Amfil Technologies Inc. Signs L.O.I. to Acquire Snakes & Lagers Inc; Anticipates $2 Million - $3 Million in Additional Annual Revenue
Marketwired - Mon Apr 04, 8:01AM CDT
Amfil Technologies Inc. (OTC PINK: AMFE) is pleased to announce that it has signed a Letter Of Intent for the acquisition of all the assets and rights, therein owned by Snakes & Lagers Inc., as well as the first right of refusal on all future Snakes & Lattes Inc. franchises worldwide.
Amfil Technologies Inc. and The GroZone Product Line Ready For Legalization Across Canada After Liberal Majority Government Win In Last Night's Election
ACCESSWIRE - Tue Oct 20, 8:25AM CDT
TORONTO, ON / ACCESSWIRE / October 20, 2015 / Amfil Technologies Inc. (OTC Pink: AMFE) (PINKSHEETS: AMFE), provider of custom engineering and integration of ozone based technology for the medical marijuana manufacturing industry through the GROzone line of products is pleased to provide the following shareholder update.
Amfil Technologies Inc. Files Provisional Patent Application with the United States Patent and Trademark Office for GROzone Technology Protection; Receives Patent Pending Number
ACCESSWIRE - Mon Aug 03, 7:31AM CDT
TORONTO, ON / ACCESSWIRE / August 3, 2015 / Amfil Technologies Inc. (OTC Pink: AMFE) (PINKSHEETS: AMFE), provider of custom engineering and integration of ozone based technology for the medical marijuana manufacturing industry through the GROzone line of products, today announced that it has submitted a provisional patent application with the United States Patent & Trademark Office under the Patent Cooperation Treaty (PCT) encompassing the ozone technology and delivery system used in the GROzone gaseous and aqueous systems.
Amfil Technologies Inc. Selected for Inclusion in The Marijuana Index
eTeligis - Mon Jul 20, 8:00AM CDT
TORONTO, ON, Canada, via ETELIGIS INC., 07/20/2015 - - AMFIL Technologies, Inc. (OTC Pink: AMFE) (PINKSHEETS: AMFE), provider of custom engineering and integration of ozone based technology for the medical marijuana manufacturing industry through the GROzone line of products, today announced that it has been selected for inclusion in The Marijuana Index's US Non-Reporting Index and Global Composite Index. (www.marijuanaindex.com)
The Cannabis Financial Network Highlights Amfil Technologies Inc. and The GROzone Product Line in Video Interview and Article
ACCESSWIRE - Wed Jun 24, 9:01AM CDT
TORONTO, ON / ACCESSWIRE / June 24, 2015 / Amfil Technologies Inc. (OTC Pink: AMFE) (PINKSHEETS: AMFE), is pleased to announce that the company worked with the Cannabis Financial Network on producing a corporate video which gives a brief overview on the company and more specifically outlines the Grozone Project led by scientist and inventor of the technology, Mr. Ambrose Fillis.
Amfil Technologies, Inc. Announces Shareholder Update on Audited Financial Statement Submission and Grozone Product Line Developments
eTeligis - Tue May 12, 8:09PM CDT
TORONTO, ON, Canada, via ETELIGIS INC., 05/12/2015 - - Amfil Technologies, Inc. (OTC Pink: AMFE) (PINKSHEETS: AMFE) Announces the Filing of a Form 15 followed by a voluntary 10k which includes two years audited financial statements covering year ended June 30th 2013 and June 30th 2014 with the U.S. Securities and Exchange Commission (SEC) in connection with the company's previously announced intentions to regain its fully reporting status.
Amfil Technologies, Inc. Issues Shareholder Update on Audited Financial Statement Submission and Grozone Product Line Developments
ACCESSWIRE - Tue May 12, 6:13PM CDT
TORONTO, ON / ACCESSWIRE / May 12, 2015 / Amfil Technologies, Inc. (OTC Pink: AMFE) (PINKSHEETS: AMFE) Announces the Filing of a Form 15 followed by a voluntary 10k which includes two years audited financial statements covering year ended June 30th 2013 and June 30th 2014 with the U.S. Securities and Exchange Commission (SEC) in connection with the company's previously announced intentions to regain its fully reporting status.
Easton Pharmaceuticals Inc. Provides Update on the AMFIL GroZone Technology for the Medical Marijuana Industry and Moves Towards Implementation Within Medicated Markets California Operations
Marketwired - Mon Mar 02, 7:01AM CST
Easton Pharmaceuticals Inc. (OTC PINK: EAPH) Provides update on the AMFIL GroZone technology and its related investment in AMFIL Technologies Inc. for the medical marijuana industry; Moves towards implementation in Medicated Markets, California Medical Marijuana Operations. Highlights projected goals towards the venture for the month of March.
Easton Pharmaceuticals Inc. Suspends All Potentially Dilutive Financing as a Direct Result of Negotiations With a Major California Based Medical Marijuana Grow-Op
Marketwired - Mon Dec 22, 7:01AM CST
Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces it has suspended all types of financings considered more dilutionary compared to other financing options currently available.
Novus MedPlan Cost-Saving Provider Network Offers A Strong Value Proposition
ACCESSWIRE - Fri Nov 07, 8:01AM CST
WHITEFISH, MT / ACCESSWIRE / November 7, 2014 / Marijuana reform was a key ballot initiative in seven states (as well as 17 municipalities and D.C.) this week, with more drug policy reform questions (most aimed at reforming or out outright repealing marijuana laws) on the ballot than at any time in the history of the country. In California, Proposition 47 was passed, transforming the lowest-level non-violent crimes like simple drug possession, from a felony to a misdemeanor, freeing up an estimated $1B per annum to be dedicated to useful things like crime prevention, school funding, mental health treatment, and victim services. Regulatory reforms like this are opening up sizable markets for both private and public sector participants.
GWPH: 89.45 (-1.69)